Cargando…

Quality of healthcare and admission rates for acute cardiac events during COVID-19 pandemic: a retrospective cohort study on ST-segment-elevation myocardial infarction in China

OBJECTIVE: To evaluate changes in admission rates for and quality of healthcare of ST-segment-elevation myocardial infarction (STEMI) during the period of the COVID-19 outbreak and postoutbreak. METHODS: We conducted a retrospective study among patients with STEMI in the outbreak time and the postou...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Junxiong, Zhou, Shuduo, Li, Na, Dong, Xuejie, Maimaitiming, Mailikezhati, Yue, Dahai, Jin, Yinzi, Zheng, Zhi-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659714/
https://www.ncbi.nlm.nih.gov/pubmed/36357000
http://dx.doi.org/10.1136/bmjopen-2021-059720
_version_ 1784830257393565696
author Ma, Junxiong
Zhou, Shuduo
Li, Na
Dong, Xuejie
Maimaitiming, Mailikezhati
Yue, Dahai
Jin, Yinzi
Zheng, Zhi-Jie
author_facet Ma, Junxiong
Zhou, Shuduo
Li, Na
Dong, Xuejie
Maimaitiming, Mailikezhati
Yue, Dahai
Jin, Yinzi
Zheng, Zhi-Jie
author_sort Ma, Junxiong
collection PubMed
description OBJECTIVE: To evaluate changes in admission rates for and quality of healthcare of ST-segment-elevation myocardial infarction (STEMI) during the period of the COVID-19 outbreak and postoutbreak. METHODS: We conducted a retrospective study among patients with STEMI in the outbreak time and the postoutbreak time. DESIGN: To examine the changes in the admission rates and in quality of healthcare, by comparison between periods of the postoutbreak and the outbreak, and between the postoutbreak and the corresponding periods. SETTING: Data for this analysis were included from patients discharge diagnosed with STEMI from all the hospitals of Suzhou in each month of the year until the end of July 2020. PARTICIPANTS: 1965 STEMI admissions. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome was the number of moecondary outcomnthly STEMI admissions, and the secondary outcomes were the quality metrics of STEMI healthcare. RESULTS: There were a 53% and 38% fall in daily admissions at the phase of outbreak and postoutbreak, compared with the 2019 corresponding. There remained a gap in actual number of postoutbreak admissions at 306 and the predicted number at 497, an estimated 26 deaths due to STEMI would have been caused by not seeking healthcare. Postoutbreak period of 2020 compared with corresponding period of 2019, the percentage of cases transferred by ambulance decreased from 9.3% to 4.2% (p=0.013), the door-to-balloon median time increased from 17.5 to 34.0 min (p=0.001) and the rate of percutaneous coronary intervention (PCI) therapy declined from 71.3% to 60.1% (p=0.002). CONCLUSIONS: The impact of public health restrictions may lead to unexpected out-of-hospital deaths and compromised quality of healthcare for acute cardiac events. Delay or absence in patients should be continuously considered avoiding the secondary disaster of the pandemic. System delay should be modifiable for reversing the worst clinical outcomes from the COVID-19 outbreak, by coordination measures with focus on the balance between timely PCI procedure and minimising contamination of cardiac catheterisation rooms.
format Online
Article
Text
id pubmed-9659714
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-96597142022-11-14 Quality of healthcare and admission rates for acute cardiac events during COVID-19 pandemic: a retrospective cohort study on ST-segment-elevation myocardial infarction in China Ma, Junxiong Zhou, Shuduo Li, Na Dong, Xuejie Maimaitiming, Mailikezhati Yue, Dahai Jin, Yinzi Zheng, Zhi-Jie BMJ Open Health Policy OBJECTIVE: To evaluate changes in admission rates for and quality of healthcare of ST-segment-elevation myocardial infarction (STEMI) during the period of the COVID-19 outbreak and postoutbreak. METHODS: We conducted a retrospective study among patients with STEMI in the outbreak time and the postoutbreak time. DESIGN: To examine the changes in the admission rates and in quality of healthcare, by comparison between periods of the postoutbreak and the outbreak, and between the postoutbreak and the corresponding periods. SETTING: Data for this analysis were included from patients discharge diagnosed with STEMI from all the hospitals of Suzhou in each month of the year until the end of July 2020. PARTICIPANTS: 1965 STEMI admissions. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome was the number of moecondary outcomnthly STEMI admissions, and the secondary outcomes were the quality metrics of STEMI healthcare. RESULTS: There were a 53% and 38% fall in daily admissions at the phase of outbreak and postoutbreak, compared with the 2019 corresponding. There remained a gap in actual number of postoutbreak admissions at 306 and the predicted number at 497, an estimated 26 deaths due to STEMI would have been caused by not seeking healthcare. Postoutbreak period of 2020 compared with corresponding period of 2019, the percentage of cases transferred by ambulance decreased from 9.3% to 4.2% (p=0.013), the door-to-balloon median time increased from 17.5 to 34.0 min (p=0.001) and the rate of percutaneous coronary intervention (PCI) therapy declined from 71.3% to 60.1% (p=0.002). CONCLUSIONS: The impact of public health restrictions may lead to unexpected out-of-hospital deaths and compromised quality of healthcare for acute cardiac events. Delay or absence in patients should be continuously considered avoiding the secondary disaster of the pandemic. System delay should be modifiable for reversing the worst clinical outcomes from the COVID-19 outbreak, by coordination measures with focus on the balance between timely PCI procedure and minimising contamination of cardiac catheterisation rooms. BMJ Publishing Group 2022-11-10 /pmc/articles/PMC9659714/ /pubmed/36357000 http://dx.doi.org/10.1136/bmjopen-2021-059720 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Health Policy
Ma, Junxiong
Zhou, Shuduo
Li, Na
Dong, Xuejie
Maimaitiming, Mailikezhati
Yue, Dahai
Jin, Yinzi
Zheng, Zhi-Jie
Quality of healthcare and admission rates for acute cardiac events during COVID-19 pandemic: a retrospective cohort study on ST-segment-elevation myocardial infarction in China
title Quality of healthcare and admission rates for acute cardiac events during COVID-19 pandemic: a retrospective cohort study on ST-segment-elevation myocardial infarction in China
title_full Quality of healthcare and admission rates for acute cardiac events during COVID-19 pandemic: a retrospective cohort study on ST-segment-elevation myocardial infarction in China
title_fullStr Quality of healthcare and admission rates for acute cardiac events during COVID-19 pandemic: a retrospective cohort study on ST-segment-elevation myocardial infarction in China
title_full_unstemmed Quality of healthcare and admission rates for acute cardiac events during COVID-19 pandemic: a retrospective cohort study on ST-segment-elevation myocardial infarction in China
title_short Quality of healthcare and admission rates for acute cardiac events during COVID-19 pandemic: a retrospective cohort study on ST-segment-elevation myocardial infarction in China
title_sort quality of healthcare and admission rates for acute cardiac events during covid-19 pandemic: a retrospective cohort study on st-segment-elevation myocardial infarction in china
topic Health Policy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659714/
https://www.ncbi.nlm.nih.gov/pubmed/36357000
http://dx.doi.org/10.1136/bmjopen-2021-059720
work_keys_str_mv AT majunxiong qualityofhealthcareandadmissionratesforacutecardiaceventsduringcovid19pandemicaretrospectivecohortstudyonstsegmentelevationmyocardialinfarctioninchina
AT zhoushuduo qualityofhealthcareandadmissionratesforacutecardiaceventsduringcovid19pandemicaretrospectivecohortstudyonstsegmentelevationmyocardialinfarctioninchina
AT lina qualityofhealthcareandadmissionratesforacutecardiaceventsduringcovid19pandemicaretrospectivecohortstudyonstsegmentelevationmyocardialinfarctioninchina
AT dongxuejie qualityofhealthcareandadmissionratesforacutecardiaceventsduringcovid19pandemicaretrospectivecohortstudyonstsegmentelevationmyocardialinfarctioninchina
AT maimaitimingmailikezhati qualityofhealthcareandadmissionratesforacutecardiaceventsduringcovid19pandemicaretrospectivecohortstudyonstsegmentelevationmyocardialinfarctioninchina
AT yuedahai qualityofhealthcareandadmissionratesforacutecardiaceventsduringcovid19pandemicaretrospectivecohortstudyonstsegmentelevationmyocardialinfarctioninchina
AT jinyinzi qualityofhealthcareandadmissionratesforacutecardiaceventsduringcovid19pandemicaretrospectivecohortstudyonstsegmentelevationmyocardialinfarctioninchina
AT zhengzhijie qualityofhealthcareandadmissionratesforacutecardiaceventsduringcovid19pandemicaretrospectivecohortstudyonstsegmentelevationmyocardialinfarctioninchina